Gil M. Labrucherie

Filings by Gil M. Labrucherie span 4 companies, the busiest being Nektar Therapeutics, Rezolute, Inc. and Septerna, Inc. The record holds 19 filings, for trades running from 19 January 2016 to 19 November 2025.

Market trades split into 4 purchases (€465k) and 6 sales (€529k). The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 6 share grants and 2 option exercises. So far in 2025, the count stands at 2 purchases and no sales.

The median purchase comes to €122k. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 21 November 2025 with a share grant in Rezolute, Inc. The last purchase on record was published on 27 February 2025, which is 598 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.